Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studies

Reuben Benjamin, Charlotte Graham, Deborah Yallop, +135

The Lancet

Hematological MalignancyCell TherapyTransplantationMedicineHematology +7

Once-per-week selinexor, bortezomib, and dexamethasone versus twice-per-week bortezomib and dexamethasone in patients with multiple myeloma (BOSTON): a randomised, open-label, phase 3 trial

Sebastian Grosicki, Maryana Simonova, Ivan Špıčka, +55

The Lancet

Hematological MalignancyOnce-per-week SelinexorMedicineHematologyMyeloid Neoplasia +5

Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial

Meletios Α. Dimopoulos, Francesca Gay, Fredrik Schjesvold, +187

The Lancet

Regenerative MedicineCell TherapyTransplantationMarrow TransplantationPlacebo-controlled Phase 3 +5

LocoMMotion: a prospective, non-interventional, multinational study of real-life current standards of care in patients with relapsed and/or refractory multiple myeloma

María‐Victoria Mateos, Katja Weisel, Valerio De Stefano, +30

Leukemia

Relapsed/refractory MmCancer ManagementImmunologySurgeryPharmacotherapy +16

Tolerance to rat monoclonal antibodies. Implications for serotherapy.

Reuben Benjamin, Stephen Cobbold, Mike Clark, +1

The Journal of Experimental Medicine

Immune ToleranceMab TherapyImmunologyImmunodominanceAntigen Processing +16

Allogeneic Hematopoietic Stem Cell Transplantation and Norovirus Gastroenteritis: A Previously Unrecognized Cause of Morbidity

Claire Roddie, Joel Paul, Reuben Benjamin, +7

Clinical Infectious Diseases

UCART19, a first-in-class allogeneic anti-CD19 chimeric antigen receptor T-cell therapy for adults with relapsed or refractory B-cell acute lymphoblastic leukaemia (CALM): a phase 1, dose-escalation trial

Reuben Benjamin, Nitin Jain, Marcela V. Maus, +92

The Lancet Haematology

Hematological MalignancyLymphoid NeoplasiaCell TherapyMedicineImmunology +8

Acute Immune Signatures and Their Legacies in Severe Acute Respiratory Syndrome Coronavirus-2 Infected Cancer Patients

Sultan Abdul-Jawad, Luca Baù, Thanussuyah Alaguthurai, +48

Cancer Cell

Their LegaciesViral PersistenceViral DiagnosticsRespiratory DiseasesImmunology +8

Abstract 3499: CD56 targeted chimeric antigen receptors for immunotherapy of multiple myeloma

Reuben Benjamin, Maud Condomines, Gertrude Gunset, +1

Cancer Research

ImmunologyImmune RegulationImmunologic MechanismAntigen ProcessingImmunotherapeutics +20

Outcomes in patients treated with chimeric antigen receptor T-cell therapy who were admitted to intensive care (CARTTAS): an international, multicentre, observational cohort study

Élie Azoulay, Pedro Castro, Adel Maamar, +73

The Lancet Haematology

Clinical ImmunologyTranslational MedicineCell TherapyAutoimmune DiseaseAcute Care +6